The Board of Regents of The University of Texas System appointed William L. Henrich, M.D., as president of the UT Health Science Center at San Antonio.

Henrich has been serving as the institution’s interim president since February and was named the sole finalist for the position last month. Previously, he served as vice president for medical affairs and dean of the Health Science Center's School of Medicine. He also holds the John P. Howe, III, M.D. Distinguished Chair in Health Policy.
Click here for the Full Story.

VMH Health was named one of the most promising Life Science companies at the 8th Annual Rice Alliance for Technology & Entrepreneurship Life Science Venture Forum in Houston in June. Life science companies showcased their new ventures for an audience of more than 400 attendees, including investors, venture capitalists, industry representatives, business leaders, advisors/mentors, service providers, and entrepreneurs.

Based in Temple with offices in San Antonio and College Station. VMH Health is a spin-out company from Texas A&M Health Science Center and Scott and White Healthcare, The company has licensed patented technologies from these organizations to develop a diagnostic device and therapy for essential hypertension. The company is working with INCELL Corporation in San Antonio to manufacture the prototypes for diagnostic testing and therapeutics, and continues a collaborative effort with Texas A&M Health Science Center and Scott and White Healthcare to develop and commercialize the company’s products.
Click here for the Full Story.

Two of the world's leading Alzheimer's researchers, George Perry, dean of the UTSA College of Sciences, and Ricardo B. Maccioni, neurology professor at the University of Chile Medical School, have co-edited a book analyzing the major new developments in the diagnosis and treatment of Alzheimer's disease.
Today's headlines. Building on a 2007 Alzheimer's disease conference in Chile, the researchers edited "Current Hypotheses and Research Milestones in Alzheimer's Disease," a 254-page text written by academics and medical doctors. The book focuses on the most promising hypotheses that illuminate the path to more effective treatment.
Click here for the Full Story.

Medtronic, Inc. (NYSE: MDT) announced on May 11, 2009 that the company has chosen San Antonio, Texas, as the home of its new Diabetes Therapy Management and Education Center. Medtronic is expected to hire nearly 1,400 professionals during a five-year period to staff the new 150,000-square-foot facility.

The announcement took place on May 11, 2009 at the Overlook at the Rim office building, the proposed site for the new center. Medtronic expects to begin recruiting immediately with the facility opening for operations in late summer.
Click here for the company announcement.
See story on site selection process.

Two San Antonio research institutions have signed an exclusive license and research agreement with pharmaceutical giant Merck & Co. Inc. to work on a new vaccine for chlamydia.

The University of Texas at San Antonio and the University of Texas Health Science Center at San Antonio will develop a treatment option that, one day, could target the sexually transmitted bacteria Chlamydia trachomatis.
Click here for the Full Story.

Seno Medical Instruments Inc. has received recognition from Frost & Sullivan as one of the top emerging medical companies in the nation. The San Antonio-based diagnostic firm is commercializing a new way to detect and to develop treatment for breast cancer and cardiovascular disease.

Market research firm Frost & Sullivan will present the 2009 North American Medical Imaging Emerging Company of the Year Award on March 18 in San Francisco.
Click here for the Full Story.

While the national economy struggles, the Texas life science industry is thriving and is poised to be a generator of new jobs for years to come – especially with continued nurturing by the state. That was the consensus of state and national leaders in biotechnology, business development, higher education and pharmaceutical research who gathered today at the second annual Texas Biz Bio Conference in Austin.

Sponsored by the Texas Healthcare and Bioscience Institute (THBI) and other leaders in life science and business, including BioMed SA, the event – The Texas Life Science Industry: Competing in a Global Economy – featured a distinguished list of speakers from Texas and across the country, led by Governor Rick Perry.
Click here for the Full Story.

BioMed SA completed its third full year of operation in 2008 with continued progress towards achieving the organization's mission - to promote San Antonio's healthcare and bioscience assets to accelerate growth of the sector and enhance San Antonio's reputation as a city of science and health. For a review of our strategic accomplishments, see "Celebrate the Science of San Antonio"

JEOL, maker of the world's most advanced electron microscope, has built only one — a demo model that sits in the company's factory in Japan. The second will be here, housed at the University of Texas at San Antonio's advanced microscopy laboratory.
Thanks to a $1.2 million gift from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation — heirs to the mighty King Ranch fortune — UTSA is purchasing the powerful microscope to aid breakthroughs in cancer therapy, electronics and solar panels and will invite scientists from all over the world to use the new tool.
FOR FULL STORY.

William Henrich, dean of the medical school at the University of Texas Health Science Center at San Antonio, has been named interim president of the health science center upon the departure of Francisco Cigarroa, who was appointed chancellor of the UT System last week.

Henrich will start Feb. 2, when Cigarroa leaves for his new job in Austin. He will serve as interim while a search committee looks for a long-term successor for Cigarroa.
FOR FULL STORY.

University of Texas System regents officially named Francisco Cigarroa, a transplant surgeon from Laredo, as chancellor Friday, making him the first Hispanic in the nation to lead a large public university system.

Cigarroa, who begins his new job Feb. 2, is president of the University of Texas Health Science Center at San Antonio.

FOR FULL STORY.

San Antonio, TX – One of the nation’s leading advocates for the promotion of effective disease management, chronic care and preventive healthcare has recognized San Antonio-based WellMed Medical Management, Inc. for its groundbreaking Disease Management program.

DMAA: The Care Continuum Alliance (www.DMAA.org) awarded WellMed leaders its Outstanding Quality Initiative Award November 24 in Hollywood, Florida during the Population Health Improvement Leadership Awards luncheon at the 10th annual meeting of the Disease Management Association of America. The award recognizes outstanding achievements in and contributions to the science and practice of chronic disease care.
FOR FULL STORY.